Search
for
Sort by
Research 30 of 1000+
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
- LO-009 Responsiveness of the CLASI to alopecia and mucous membrane involvement: a retrospective study of prospectively collected data
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- Comparative Analysis of Labeling and Claim Substantiation Requirements for Herbal Hair Products across Different Regulatory Jurisdictions
- Claims for the cost of care: local authority provision
- Extraordinary claims without extraordinary evidence: controversy on anti‐androgen therapy for COVID‐19
- Wellness claims and men’s health: Bridging the counseling gap in urology
- Validation of alopecia coding in US claims data among women of childbearing age
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Scientific Opinion on the substantiation of health claims related to spermidine and contribution to normal hair growth (ID 1705) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
- Purpose-limited pharmaceutical product claims under the revised European Patent Convention: A camouflaged attack on generic substitution?
- Limiting Initial Interest Confusion Claims in Keyword Advertising
- Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Ethno-medico-botanical claims of Bondla wildlife sanctuary vicinity of Goa
- 0519 Social media claims and tolerability of topical tretinoin plus topical minoxidil for androgenetic alopecia
- UK High Court Revokes Escitalopram UK Patent; Validity of Second Medical use Claims Based on Dosage Regimes in the UK; Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings
- Magnesium and calsium in hair correlated with cerebral blood flow in the normal aged.
- Actualización terapéutica en corticoesteroides tópicos: clasificación, usos clínicos y efectos colaterales
- Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment …
- Red Light Therapy in Cosmetic Dermatology: Marketing Claims Backed by Evidence?
- Scientific Validation of "Clinically Proven" Claims: Compliance Focused and Global Regulatory Insights
- LibGuides: L3Y2 Tutorial 2022 - critical thinking: Claim 5: Caffeine reduces hair loss
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- Scientific Opinion on the substantiation of a health claim related to KF2BL20 and maintenance of normal hair pursuant to Article 13(5) of Regulation (EC) No 1924/2006
- Scientific Opinion on the substantiation of a health claim related to a combination of thiamin, riboflavin, niacin, pantothenic acid, pyridoxine, D‐biotin and pumpkin seed oil and maintenance of normal hair pursuant to Article 13(5) of Regulation (EC) No 1924/2006
- Scientific Opinion on the substantiation of a health claim related to spermidine and prolongation of the growing phase (anagen) of the hair cycle pursuant to Article 13(5) of Regulation (EC) No 1924/2006
- Infectious Diseases 2015: The antimicrobial peptides delivery strategies based on nanotechnology to treat infectious diseases - Groo Anne-Claire - University of Angers